292 related articles for article (PubMed ID: 10667416)
1. The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens.
Costes V; Magen V; Legouffe E; Durand L; Baldet P; Rossi JF; Klein B; Brochier J
Hum Pathol; 1999 Dec; 30(12):1405-11. PubMed ID: 10667416
[TBL] [Abstract][Full Text] [Related]
2. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
3. Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.
Carbone A; Gloghini A; Gattei V; Degan M; Improta S; Aldinucci D; Canzonieri V; Perin T; Volpe R; Gaidano G; Zagonel V; Pinto A
Blood; 1997 May; 89(10):3787-94. PubMed ID: 9160685
[TBL] [Abstract][Full Text] [Related]
4. CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms.
O'Connell FP; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2004 Feb; 121(2):254-63. PubMed ID: 14983940
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
6. [Syndecan-1 (CD138): an immunohistochemical marker of plasma cell tumors].
Fakan F; Boudová L; Hejda C
Cesk Patol; 2002 Jan; 38(1):33-6. PubMed ID: 11933459
[TBL] [Abstract][Full Text] [Related]
7. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
[TBL] [Abstract][Full Text] [Related]
8. Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells.
Gattei V; Godeas C; Degan M; Rossi FM; Aldinucci D; Pinto A
Br J Haematol; 1999 Jan; 104(1):152-62. PubMed ID: 10027728
[TBL] [Abstract][Full Text] [Related]
9. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
10. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
11. A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.
Wijdenes J; Vooijs WC; Clément C; Post J; Morard F; Vita N; Laurent P; Sun RX; Klein B; Dore JM
Br J Haematol; 1996 Aug; 94(2):318-23. PubMed ID: 8759892
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell quantification in bone marrow by computer-assisted image analysis.
Went P; Mayer S; Oberholzer M; Dirnhofer S
Histol Histopathol; 2006 Sep; 21(9):951-6. PubMed ID: 16763944
[TBL] [Abstract][Full Text] [Related]
13. [Determination proliferative activity of myeloma cells in histologic material].
Fabian P; Kren L; Nenutil R
Cesk Patol; 2004 Apr; 40(2):46-9. PubMed ID: 15233016
[TBL] [Abstract][Full Text] [Related]
14. C-kit receptor (CD117) expression on plasma cells in monoclonal gammopathies.
Kraj M; Pogłód R; Kopeć-Szlezak J; Sokołowska U; Woźniak J; Kruk B
Leuk Lymphoma; 2004 Nov; 45(11):2281-9. PubMed ID: 15512818
[TBL] [Abstract][Full Text] [Related]
15. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1.
Bayer-Garner IB; Korourian S
Mod Pathol; 2001 Sep; 14(9):877-9. PubMed ID: 11557783
[TBL] [Abstract][Full Text] [Related]
16. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
17. Bone-marrow plasmocytosis--an immunohistological study.
Eckert F; Schmid L; Kradolfer D; Schmid U
Blut; 1986 Jul; 53(1):11-9. PubMed ID: 3719110
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
19. [Immunophenotyping of B lymphoma in bone marrow biopsies. Contribution of 4 monoclonal antibodies used on paraffin-embedded tissues:DDB.42,DNA.7,DNA.44 and DND.53].
Meuge-Moraw C; Bernard MC; Delacretaz F
Ann Pathol; 1993; 13(3):151-6. PubMed ID: 8397539
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1/CD138 expression in normal myeloid, acute lymphoblastic and myeloblastic leukemia cells.
Seftalioglu A; Karakus S
Acta Histochem; 2003; 105(3):213-21. PubMed ID: 13677614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
